Solventum PE Ratio 2023-2026 | SOLV

Current and historical p/e ratio for Solventum (SOLV) from 2023 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Solventum PE ratio as of September 14, 2026 is 12.65.

Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Solventum PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-09-15 90.06 11.00
2026-06-30 77.15 $8.19 9.42
2026-03-31 65.30 $8.17 7.99
2025-12-31 79.24 $8.88 8.92
2025-09-30 73.00 $8.69 8.40
2025-06-30 75.84 $2.17 34.95
2025-03-31 76.04 $2.17 35.04
2024-12-31 66.06 $2.76 23.93
Sector Industry Market Cap Revenue
Medical Medical Services $15.290B $8.325B
Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.882B 25.03
CVS Health (CVS) United States $122.206B 12.19
HCA Healthcare (HCA) United States $92.119B 14.32
Elevance Health (ELV) United States $92.005B 14.44
Cencora (COR) United States $62.254B 19.02
Natera (NTRA) United States $49.267B 0.00
Labcorp Holdings (LH) United States $25.572B 18.03
Viatris (VTRS) United States $19.136B 6.61
Medpace Holdings (MEDP) United States $16.619B 34.90
DiDi Global (DIDIY) China $16.275B 178.51
EUROFINS SCIENT (ERFSF) Luxembourg $16.114B 0.00
Revvity (RVTY) United States $14.338B 24.02
Charles River Laboratories (CRL) United States $13.038B 27.59
ICON (ICLR) Ireland $12.935B 17.58
BrightSpring Health Services (BTSG) United States $11.931B 41.02
Avantor (AVTR) United States $10.254B 18.49
BioMerieux (BMXMF) France $10.192B 0.00
HealthEquity (HQY) United States $7.944B 25.89
Caris Life Sciences,�Inc (CAI) United States $7.362B 72.36
PACS (PACS) United States $7.051B 23.70
Sonic Healthcare (SKHHY) Australia $6.687B 0.00
GETINGE (GNGBY) Sweden $6.654B 18.79
CochLear (CHEOY) Australia $6.355B 0.00
Bausch + Lomb (BLCO) Canada $6.282B 23.76
MiniMed (MMED) United States $6.181B 0.00
Sotera Health (SHC) United States $5.285B 21.79
Concentras Parent (CON) United States $4.566B 22.52
Organon (OGN) United States $3.585B 4.55
CareDx (CDNA) United States $2.709B 308.06
Alignment Healthcare (ALHC) United States $2.684B 68.11
GeneDx Holdings (WGS) United States $2.676B 249.28
Amplifon S.p.A (AMFPF) Italy $2.466B 12.74
Pediatrix Medical (MD) United States $2.187B 12.81
Establishment Labs Holdings (ESTA) United States $2.143B 0.00
Progyny (PGNY) United States $2.137B 30.27
COMPASS Pathways (CMPS) United Kingdom $2.013B 0.00
Sonida Senior Living (SNDA) United States $1.914B 0.00
Surgery Partners (SGRY) United States $1.838B 70.20
Bora Pharmaceuticals, - (BORAY) Taiwan $1.695B 10.18
Freenome (FRNM) United States $1.607B 0.00
Ardent Health (ARDT) United States $1.552B 8.87
Agilon Health (AGL) United States $1.551B 0.00
Nutex Health (NUTX) United States $1.486B 8.52
InnovAge Holding (INNV) United States $1.470B 0.00
Omada Health (OMDA) United States $1.255B 256.25
Ryman Healthcare (RYHTY) New Zealand $1.241B 0.00
GoodRx Holdings (GDRX) United States $1.220B 23.73
Teladoc Health (TDOC) United States $1.181B 0.00
CryoPort (CYRX) United States $0.808B 0.00
GMR Solutions (GMRS) United States $0.716B 0.00
Enhabit (EHAB) United States $0.709B 25.89
Forward Industries (FWDI) United States $0.513B 0.00
Oncology Institute (TOI) United States $0.507B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.504B 0.00
Strata Critical Medical (SRTA) United States $0.474B 0.00
SBC Medicals (SBC) United States $0.467B 9.66
Shoulder Innovations (SI) United States $0.382B 0.00
Auna S.A (AUNA) Luxembourg $0.377B 5.47
Embecta (EMBC) United States $0.297B 2.57
Biodesix (BDSX) United States $0.289B 0.00
So-Young (SY) China $0.266B 0.00
LifeMD (LFMD) United States $0.166B 0.00
Ascend Wellness Holdings (AAWH) United States $0.109B 0.00
Park Dental Partners (PARK) United States $0.101B 0.00
SkinHealth Systems (SKIN) United States $0.091B 0.00
Sera Prognostics (SERA) United States $0.079B 0.00
QDM (QDMI) Hong Kong, SAR China $0.065B 7.65
Tevogen (TVGN) United States $0.049B 0.00
DocGo (DCGO) United States $0.037B 0.00
Lifeward (LFWD) United States $0.020B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.014B 0.00
Basel Medical Group (BMGL) Singapore $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
XWELL (XWEL) United States $0.008B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
Aclarion (ACON) United States $0.007B 0.00
IceCure Medical (ICCM) Israel $0.007B 0.00
20/20 Biolabs (AIDX) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
Pheton Holdings (PTHL) China $0.006B 0.00
Pomdoctor - (POM) China $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Synergy CHC (SNYR) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00